April 24, 2017 Environ, Ag./Food & Bev Lab Equipment PR/Corporate

Xylem executives to share perspectives on the water sector’s growing adoption of smart water technologies at Global Water Summit 2017

RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 24, 2017– Executives from leading global water technology company Xylem (NYSE: XYL), including President and CEO Patrick Decker, will participate in forums focused on examining emerging trends in the water sector, particularly the adoption of smart technologies, at the Global Water Summit 2017, taking place in Madrid, Spain on April 24-25.... Read more

April 24, 2017 Acad, Gov/Utilities M&A, Partnerships Materials Analysis Uncategorized

MTS Leading Edge Materials Testing Capabilities Drive Advances In U.S. Air Force's Aircraft Design

EDEN PRAIRIE, MN, April 24, 2017 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, has strengthened its global reputation as the industry leader in materials and structures testing for mission critical purposes. Through application of its comprehensive materials test technology, MTS is playing an integral part in... Read more

April 24, 2017 Clinical Research/Diagn. Microscopy

On-Demand Webinar: Quality with Confidence – What you need to know about digital microscopes for medical device quality processes

Digital microscopes – without eyepieces – are being used more frequently for quality inspection because of their ease of use, enhanced capabilities in 2D and 3D analysis, and reliable and repeatable results. This webinar from Leica will clear up common misconceptions about digital magnification, resolution and megapixels, and explain why optics in digital microscopes are... Read more

April 24, 2017 Microscopy Product Launch

New technologies augment the surgeon’s visualization

GLOW800 augmented reality fluorescence integrated with a M530 OH6 neurosurgical microscope. Photo courtesy of Cleopatra Charalampaki, MD, PhD, Professor of Neurosurgery, Department of Neurosurgery, Cologne Medical Center, Germany Leica Microsystems will be revealing a new generation of augmented reality imaging technologies for surgical microscopes, at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting... Read more

April 21, 2017 Clinical Research/Diagn. Lab Top-10 Mass Spectrometry Product Launch

Bruker Introduces New Clinical Microbiology Assays and Kits at ECCMID

VIENNA, April 21, 2017 /PRNewswire/ — At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker tomorrow will introduce important new clinical microbiology assays and consumables kits to further enhance the MALDI Biotyper® (MBT) platform.  Bruker will also introduce novel, real-time PCR assays and kits for fast molecular testing of invasive aspergillosis... Read more

April 20, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases

CAMBRIDGE, UK and SAN DIEGO, USA – April 20, 2017 – Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.... Read more

April 20, 2017 Clinical Research/Diagn. Informatics & Software Licensing, IP, and Legal Life Science Tools

Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

April 20, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10

Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock

Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published in the May 2017 print issue of Critical Care Medicine. Researchers from the study, titled “Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study,” investigated the use of... Read more